Burleson Research Technologies, Inc.
Morrisville, NC Doing business as Burleson Research Technologies Inc.
- UEI
- FFAKB7DWDVK1
- CAGE
- 6LCB4
- Primary NAICS
- 541380 Testing Laboratories and Services
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 541380 Testing Laboratories and Services Primary
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 541940 Veterinary Services
- 541990 All Other Professional, Scientific, and Technical Services
- 621511 Medical Laboratories
- SAM.gov registration date
- Physical address
- 120 First Flight Ln, Morrisville, NC 27560, USA
- Website
- brt-labs.com
- Founded
- 1996
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| B516 - mouse assay's to determine the bioavailability of lead in soil and dust samples | Environmental Protection Agency | $682,200 | |
| Mouse assay's to determine the bioavailability of lead in soil and dust samples | Environmental Protection Agency | $564,000 | |
| Support services for assessing lead bioavailability in environmental media - this task order is a ratification for… | Cincinnati Procurement Operations Division | $0 | |
| Assessing lead bioavailability in environmental media internal task order 1 against burleson IDIQ 68HERC23D0012 | Cincinnati Procurement Operations Division | $519,400 | |
| Project - in vivo mouse assays for lead bioavailability study | Office of Research and Development | $242,000 |
About Burleson Research Technologies, Inc.
Burleson Research Technologies, Inc., a for-profit Subchapter S corporation based in Morrisville, North Carolina, delivers in vivo mouse assay and environmental toxicity assessment services to the Environmental Protection Agency and the National Institutes of Health as a prime contractor (90% of recent awards) and operates without set-aside certifications. The vendor specializes in lead bioavailability testing in environmental media and genomic allergen detection services, performing work at its Morrisville facility under single-award and research-support vehicles focused on environmental health protection.
The vendor's customer base is concentrated in environmental health and toxicity assessment. The National Institute of Environmental Health Sciences anchors the portfolio by potential value ($48.7 million across 2 awards), while the EPA's Office of the Administrator ($6.2 million across 3 awards) and the EPA's Office of Research and Development ($1.1 million across 4 awards) drive award volume and steady recurring work. The Centers for Disease Control and Prevention rounds out the four customer agencies at one award. The rankings between award count and potential value diverge sharply — NIEHS carries substantially more dollars on fewer awards, while EPA ORD places more task orders at lower individual values.
Burleson holds a single-award indefinite delivery contract with EPA (valued at $4.25 million, running through December 31, 2027) under which four task orders have been issued totaling $2.7 million in combined potential value. Recent representative prime work includes a $1.36 million delivery order issued July 1, 2026, for mouse assays determining lead bioavailability in soil and dust samples (completion October 1, 2026), a $564,000 delivery order from January 28, 2025, for the same scope (completion September 30, 2026), and a $713,200 delivery order from January 1, 2024, for lead bioavailability assessments. The vendor also subcontracts to Battelle Memorial Institute on a National Institute of Environmental Health Sciences task supporting toxic and carcinogenic potential evaluations and genomic allergen rapid detection systems (awarded June 12, 2026).
Award activity is modest but consistent across the five-year window: two awards in 2026, two in 2024, and one each in 2025, 2023, and 2022, with a combined potential value of $56.1 million and $32.8 million obligated (58%). Two awards carrying $1.9 million in combined potential value reach ultimate completion within the next twenty-four months, presenting recompete exposure. Across SCI-reportable prime service contracts, Burleson invoiced $6.7 million in federal services revenue over fiscal years 2022–2024 (FY2022: $1.9 million, FY2023: $2.2 million, FY2024: $2.5 million) with a trajectory of modest growth. The SCI dataset shows roughly 3.4 to 4.2 FTEs delivered annually, with government-paid rates on prime contracts running a median of $293.82 per hour, ranging from the 10th percentile at $275.30 per hour to the 90th percentile at $389.51 per hour. The vendor builds its own delivery teams on prime work without material subcontractor engagement.
Quick answers
What is Burleson Research Technologies, Inc.'s UEI?
Burleson Research Technologies, Inc.'s Unique Entity ID (UEI) in SAM.gov is FFAKB7DWDVK1.
What is Burleson Research Technologies, Inc.'s CAGE code?
Burleson Research Technologies, Inc.'s CAGE code is 6LCB4.
What is Burleson Research Technologies, Inc.'s primary NAICS code?
Burleson Research Technologies, Inc.'s primary NAICS code is 541380 (Testing Laboratories and Services).
Where is Burleson Research Technologies, Inc. located?
Burleson Research Technologies, Inc.'s physical address in SAM.gov is 120 First Flight Ln, Morrisville, NC 27560, USA.
Is Burleson Research Technologies, Inc. registered in SAM.gov?
Yes. Burleson Research Technologies, Inc.'s SAM.gov registration is active through July 9, 2027.
What is Burleson Research Technologies, Inc.'s most recent federal award?
Burleson Research Technologies, Inc.'s most recent federal contract award is B516 - mouse assay's to determine the bioavailability of lead in soil and dust samples (68HERF26F0025), from Environmental Protection Agency, on July 1, 2026.
On GovTribe
See Burleson Research Technologies, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors